153 related articles for article (PubMed ID: 34375126)
1. Likely Common Role of Hypoxia in Driving
Yao Y; Li YM; He ZX; Civelek AC; Li XF
Cancer Biother Radiopharm; 2021 Oct; 36(8):624-631. PubMed ID: 34375126
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia and glucose metabolism in malignant tumors: evaluation by [18F]fluoromisonidazole and [18F]fluorodeoxyglucose positron emission tomography imaging.
Rajendran JG; Mankoff DA; O'Sullivan F; Peterson LM; Schwartz DL; Conrad EU; Spence AM; Muzi M; Farwell DG; Krohn KA
Clin Cancer Res; 2004 Apr; 10(7):2245-52. PubMed ID: 15073099
[TBL] [Abstract][Full Text] [Related]
3. Experimental study on "ischemic memory" of myocardium with different ischemic degrees by
Li J; Zheng N; Zhang G; Bao B; Liu L; Hao L; Wang X
Ann Nucl Med; 2020 Jan; 34(1):24-30. PubMed ID: 31637598
[TBL] [Abstract][Full Text] [Related]
4. Correlation between myocardial blood flow and fasting glucose metabolism in ischemic heart disease. Quantitative assessment by nitrogen-13 ammonia and fluorine-18 fluorodeoxyglucose positron emission tomography.
Watanabe T; Okazaki O; Akutsu Y; Yamanaka H; Michihata T; Katagiri T; Harumi K
Jpn Heart J; 1998 May; 39(3):275-85. PubMed ID: 9711179
[TBL] [Abstract][Full Text] [Related]
5. Acquisition, Processing, and Interpretation of PET
Celiker-Guler E; Ruddy TD; Wells RG
Curr Cardiol Rep; 2021 Jul; 23(9):124. PubMed ID: 34269917
[TBL] [Abstract][Full Text] [Related]
6. The effect of PPAR-γ agonist on (18)F-FDG PET imaging for differentiating tumors and inflammation lesions.
Cheong SJ; Lee CM; Kim EM; Lim ST; Sohn MH; Jeong HJ
Nucl Med Biol; 2015 Feb; 42(2):85-91. PubMed ID: 25441255
[TBL] [Abstract][Full Text] [Related]
7. Revisit 18F-fluorodeoxyglucose oncology positron emission tomography: "systems molecular imaging" of glucose metabolism.
Shen B; Huang T; Sun Y; Jin Z; Li XF
Oncotarget; 2017 Jun; 8(26):43536-43542. PubMed ID: 28402949
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and Bioevaluation of Novel [
Yang X; Wang F; Zhu H; Yang Z; Chu T
Mol Pharm; 2019 May; 16(5):2118-2128. PubMed ID: 30964298
[TBL] [Abstract][Full Text] [Related]
9. From tumor biology to clinical Pet: a review of positron emission tomography (PET) in oncology.
Kubota K
Ann Nucl Med; 2001 Dec; 15(6):471-86. PubMed ID: 11831394
[TBL] [Abstract][Full Text] [Related]
10. Pioneering and fundamental achievements on the development of positron emission tomography (PET) in oncology.
Fukuda H; Kubota K; Matsuzawa T
Tohoku J Exp Med; 2013 Jul; 230(3):155-69. PubMed ID: 23883588
[TBL] [Abstract][Full Text] [Related]
11. Additional Heparin Preadministration Improves Cardiac Glucose Metabolism Suppression over Low-Carbohydrate Diet Alone in ¹⁸F-FDG PET Imaging.
Scholtens AM; Verberne HJ; Budde RP; Lam MG
J Nucl Med; 2016 Apr; 57(4):568-73. PubMed ID: 26659348
[TBL] [Abstract][Full Text] [Related]
12. Cellular uptake of PET tracers of glucose metabolism and hypoxia and their linkage.
Busk M; Horsman MR; Jakobsen S; Bussink J; van der Kogel A; Overgaard J
Eur J Nucl Med Mol Imaging; 2008 Dec; 35(12):2294-303. PubMed ID: 18682937
[TBL] [Abstract][Full Text] [Related]
13. Generation of biological hypotheses by functional imaging links tumor hypoxia to radiation induced tissue inflammation/glucose uptake in head and neck cancer.
Zschaeck S; Zöphel K; Seidlitz A; Zips D; Kotzerke J; Baumann M; Troost EGC; Löck S; Krause M
Radiother Oncol; 2021 Feb; 155():204-211. PubMed ID: 33252044
[TBL] [Abstract][Full Text] [Related]
14. Prospective Evaluation of 18F-Fluorodeoxyglucose Uptake in Postischemic Myocardium by Simultaneous Positron Emission Tomography/Magnetic Resonance Imaging as a Prognostic Marker of Functional Outcome.
Rischpler C; Dirschinger RJ; Nekolla SG; Kossmann H; Nicolosi S; Hanus F; van Marwick S; Kunze KP; Meinicke A; Götze K; Kastrati A; Langwieser N; Ibrahim T; Nahrendorf M; Schwaiger M; Laugwitz KL
Circ Cardiovasc Imaging; 2016 Apr; 9(4):e004316. PubMed ID: 27056601
[TBL] [Abstract][Full Text] [Related]
15. Do hyperglycemia and diabetes affect the incidence of false-negative 18F-FDG PET/CT studies in patients evaluated for infection or inflammation and cancer? A Comparative analysis.
Rabkin Z; Israel O; Keidar Z
J Nucl Med; 2010 Jul; 51(7):1015-20. PubMed ID: 20554733
[TBL] [Abstract][Full Text] [Related]
16. Myocardial 18F-FDG uptake after exercise-induced myocardial ischemia in patients with coronary artery disease.
Dou KF; Yang MF; Yang YJ; Jain D; He ZX
J Nucl Med; 2008 Dec; 49(12):1986-91. PubMed ID: 18997035
[TBL] [Abstract][Full Text] [Related]
17. The reverse Warburg effect and 18F-FDG uptake in non-small cell lung cancer A549 in mice: a pilot study.
Zhang G; Li J; Wang X; Ma Y; Yin X; Wang F; Zheng H; Duan X; Postel GC; Li XF
J Nucl Med; 2015 Apr; 56(4):607-12. PubMed ID: 25722447
[TBL] [Abstract][Full Text] [Related]
18. Clinically relevant strategies for lowering cardiomyocyte glucose uptake for 18F-FDG imaging of myocardial inflammation in mice.
Thackeray JT; Bankstahl JP; Wang Y; Wollert KC; Bengel FM
Eur J Nucl Med Mol Imaging; 2015 Apr; 42(5):771-80. PubMed ID: 25389013
[TBL] [Abstract][Full Text] [Related]
19. Value and limitation of myocardial fluorodeoxyglucose single photon emission computed tomography using ultra-high energy collimators for assessing myocardial viability.
Mabuchi M; Kubo N; Morita K; Noriyasu K; Itoh Y; Katoh C; Kuge Y; Tamaki N
Nucl Med Commun; 2002 Sep; 23(9):879-85. PubMed ID: 12195093
[TBL] [Abstract][Full Text] [Related]
20. Biological correlation of ¹⁸F-FDG uptake on PET in pulmonary neuroendocrine tumors.
Kaira K; Murakami H; Endo M; Ohde Y; Naito T; Kondo H; Nakajima T; Yamamoto N; Takahashi T
Anticancer Res; 2013 Oct; 33(10):4219-28. PubMed ID: 24122985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
